Natalia Castelan

Belisario Dominguez, DIF 14080, Mexico

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 10 publications

Graft immunologic events in deceased donor kidney transplant recipients with preformed HLA-donor specific antibodies.

Graft immunologic events in deceased donor kidney transplant recipients with preformed HLA-donor specific antibodies.

Journal: Transplant immunology
Published: July 12, 2017

Anti-HLA-DQ antibodies are highly and independently related to the C1q-binding capacity of HLA antibodies.

Anti-HLA-DQ antibodies are highly and independently related to the C1q-binding capacity of HLA antibodies.

Journal: Transplant immunology
Published: October 12, 2016

Impact of pretransplant exposure to allosensitization factors generating HLA antibodies in the Luminex era.

Impact of pretransplant exposure to allosensitization factors generating HLA antibodies in the Luminex era.

Journal: Transplant immunology
Published: June 27, 2016

C1Q Assay Results in Complement-Dependent Cytotoxicity Crossmatch Negative Renal Transplant Candidates with Donor-Specific Antibodies: High Specificity but Low Sensitivity When Predicting Flow Crossmatch.

C1Q Assay Results in Complement-Dependent Cytotoxicity Crossmatch Negative Renal Transplant Candidates with Donor-Specific Antibodies: High Specificity but Low Sensitivity When Predicting Flow Crossmatch.

Journal: Journal of transplantation
Published: March 29, 2016

Pretransplant angiotensin II type 1-receptor antibodies are a risk factor for earlier detection of de novo HLA donor-specific antibodies.

Pretransplant angiotensin II type 1-receptor antibodies are a risk factor for earlier detection of de novo HLA donor-specific antibodies.

Journal: Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association
Published: December 09, 2015

C1q Assay Results in Complement-Dependent Cytotoxicity Crossmatch Negative Renal Transplant Candidates with Donor-Specific Antibodies: High Specificity But Low Sensitivity When Predicting Flow Crossmatch.

C1q Assay Results in Complement-Dependent Cytotoxicity Crossmatch Negative Renal Transplant Candidates with Donor-Specific Antibodies: High Specificity But Low Sensitivity When Predicting Flow Crossmatch.

Journal: Clinical transplants
Published: January 01, 2015

Pre-transplant angiotensin II type 1receptor antibodies: a risk factor for decreased kidney graft function in the early post-transplant period?

Pre-transplant angiotensin II type 1receptor antibodies: a risk factor for decreased kidney graft function in the early post-transplant period?

Journal: Revista de investigacion clinica; organo del Hospital de Enfermedades de la Nutricion
Published: February 26, 2014

Probability of deceased donor kidney transplantation based on % PRA.

Probability of deceased donor kidney transplantation based on % PRA.

Journal: Transplant immunology
Published: March 14, 2013

Pre-nephrectomy angiotensin II type 1 receptor antibodies in living kidney donors: A concern?

Pre-nephrectomy angiotensin II type 1 receptor antibodies in living kidney donors: A concern?

Journal: Clinical transplants
Published: January 01, 2013

Pre-transplant angiotensin II type 1 receptor antibodies: A risk factor for decreased kidney graft function in the early post-transplant period?

Pre-transplant angiotensin II type 1 receptor antibodies: A risk factor for decreased kidney graft function in the early post-transplant period?

Journal: Clinical transplants
Published: January 01, 2013
Showing 1-10 of 10

Last Updated: 09/26/2026